The real-world safety profile of sertraline: Pharmacovigilance analysis of the FAERS database
Journal of Affective Disorders · 2025
DOI: 10.1016/j.jad.2025.03.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Yanping Shu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry of Women and Children, The Second People's Hospital of Guizhou Province, Guiyang, China. Hauptthemen laut MEDLINE: Sertraline, Pharmacovigilance, Adverse Drug Reaction Reporting Systems, Antidepressive Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Guizhou Province.
Abstract (Originalsprache)
OBJECTIVE: Sertraline is a widely used antidepressant, and its safety characteristics in elderly and adolescent patients have not been fully clarified. The purpose of this study was to comprehensively evaluate the characteristics of adverse effects of sertraline through a large-scale analysis of real-world data and to add to the evidence in the elderly and adolescent populations. METHODS: The data were extracted from the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database from the first quarter (Q1) 2004 to Q1 2024 for data cleaning and analysis. Adverse drug events were analyzed using the Reporting Odds Ratio (ROR), Bayesian Confidence Propagation Neural Network (BCPNN), Proportional Reporting Ratio (PRR), and Multi-Item Gamma Poisson Shrinker (MGPS) methods. RESULTS: A total of 49,359 sertraline-related adverse event reports were included in this study. In addition to known adverse events (AEs), the study identified new potential safety signals for bruxism, microscopic colitis and genital anaesthesia. Intentional self-injury was the common adverse event in patients under 18 years of age and hyponatremia in patients 65 years of age and older. 26.77 % of adverse reactions occurred within one week of administration. CONCLUSION: Sertraline requires special attention to the risks associated with neurologic, psychiatric, and congenital disorders in clinical use. In addition to common AEs such as nausea, and tremor, newly identified adverse reactions such as genital anaesthesia, bruxism, and microscopic colitis should be guarded against. For adolescents, suicide risk monitoring should be strengthened. In elderly patients, the risk of falls and electrolyte disturbances should be emphasized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry of Women and Children, The Second People's Hospital of Guizhou Province, Guiyang, China.
- Department of Psychiatry, Beijing Haidian Psychological Rehabilitation Hospital, Beijing, China.
- Sixth Ward of Psychiatry, Hainan Anning Hospital, Hainan, China.
- Department of Student Affairs, Jiangsu University of Technology, Jiangsu, China.
- Clinical Laboratory, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, China. Electronic address: 1909229080@qq.com.
- Department of Clinical Psychology, The Third Affiliated Hospital of Soochow University, Changzhou, China. Electronic address: 2509655747@qq.com.
Förderung
- National Natural Science Foundation of China
- Science and Technology Program of Guizhou Province
Zitieren
APA
Shu, Y., Wu, Y., Guo, J., Cheng, F., Zhang, J., & Zhu, X. (2025). The real-world safety profile of sertraline: Pharmacovigilance analysis of the FAERS database. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.03.017
Vancouver
Shu Y, Wu Y, Guo J, Cheng F, Zhang J, Zhu X. The real-world safety profile of sertraline: Pharmacovigilance analysis of the FAERS database. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2025.03.017
BibTeX
@article{Shu2025,
author = {Shu, Yanping and Wu, Yan and Guo, Jiaodan and Cheng, Fangqi and Zhang, Jian and Zhu, Xianlin},
title = {The real-world safety profile of sertraline: Pharmacovigilance analysis of the FAERS database},
journal = {Journal of Affective Disorders},
year = {2025},
doi = {10.1016/j.jad.2025.03.017}
}
EUVIMED